These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12575510)

  • 1. The quandary of compounding for MCOs: administrative costs, risks, and waste.
    Kaye T
    Manag Care; 2003 Jan; 12(1):42-8. PubMed ID: 12575510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A changing order for pharmacy.
    Vogenberg FR; Pisano DJ
    Hosp Pharm; 1995 Nov; 30(11):1002, 1005-6, 1008. PubMed ID: 10152915
    [No Abstract]   [Full Text] [Related]  

  • 3. Helping to manage the high cost of rare diseases.
    Hesselgrave BL
    Manag Care Q; 2003; 11(1):1-6. PubMed ID: 12790059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operation of a radiopharmacy for a clinical trial.
    Norenberg JP; Petry NA; Schwarz S
    Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of managed care on pharmacy practice.
    Schafermeyer KW
    Pharm Pract Manag Q; 2000 Jan; 19(4):99-116. PubMed ID: 10787569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 7. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey highlights trends in managing Medicare drug costs.
    Public Sect Contract Rep; 1998 Aug; 4(8):125-7. PubMed ID: 10182909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of managed care on the retail distribution of pharmaceuticals.
    Carroll NV
    Manag Care Interface; 1998 Nov; 11(11):105-8, 111-3. PubMed ID: 10187415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management and intrusions on medical practice: striking a balance.
    Enzi MB; Kennedy EM
    Health Aff (Millwood); 2007; 26(3):678-80. PubMed ID: 17485743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing and implementing an effective specialty pharmacy service program.
    Morrow TJ
    Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy carve-out offers cost control, computer modeling.
    Capitation Manag Rep; 2002 Jul; 9(7):103-8, 97. PubMed ID: 12164058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Just what the doctor ordered: avoiding kickback pitfalls with prescription drugs.
    Simmer WS
    Manag Care Interface; 2002 Jan; 15(1):90-2. PubMed ID: 11828611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health plan pharmacy director: considerations for treatment and management of RSV disease.
    Burgoyne DS
    Manag Care; 2008 Nov; 17(11 Suppl 12):17-8, discussion 18-9. PubMed ID: 19102025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for managing injectable drugs in a managed care setting.
    Tercero W
    Manag Care Q; 2002; 10(3):16-20. PubMed ID: 12476661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Patient's Bill of Rights and the pharmacy benefit.
    Penna PM
    Manag Care Interface; 2000 Oct; 13(10):80-1. PubMed ID: 11155654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.